Eric Topol/LinkedIn
May 31, 2026, 15:41
Eric Topol: Replication of Plasma p-tau217 Blood Test for Predicting Alzheimer’s Disease
Eric Topol, Founder and Director of Scripps Research Translational Institute, shared a post on X about a recent article by Xiaqing Jiang et al., published in The Lancet, adding:
”The p-tau217 breakthrough blood test replicated again, predicting Alzheimer’s disease in a large cohort mean age 61.
The cover of the new issue is telling.”
Title: Alzheimer’s disease neuropathology plasma biomarkers and cognition in midlife: a community-based cohort study
Authors: Xiaqing Jiang, Tina D Hoang, Prof Leslie M Shaw, Prof David R Jacobs, Ilya M Nasrallah, Prof R Nick Bryan, Prof Kristine Yaffe
Other posts featuring Eric Topol on Hemostasis Today.
-
Jul 16, 2026, 20:25Ilham Benzidia: Leaving ISTH 2026 With New Ideas and New Collaborations
-
Jul 16, 2026, 20:23Eman Hassan: A Fantastic Platelets and Megakaryocytes Session at ISTH 2026
-
Jul 16, 2026, 20:22Sankara Nelson Noah II: Investigating the Temporal Dynamics of Platelet – Leukocyte Interactions in Early Sepsis
-
Jul 16, 2026, 20:20Joseph Pierre Aboumsallem: Paris Certainly Delivered This Week, and Not Just Because of the Heat
-
Jul 16, 2026, 19:53Louise St. Germain Bannon: The End of Congress, the Beginning of New Collaborations
-
Jul 16, 2026, 19:18Steve Humphreys: Learning From the Leading Experts at ISTH 2026
-
Jul 16, 2026, 19:02Kellie Machlus: Where Science Meets Friendship at ISTH 2026
-
Jul 16, 2026, 18:51Aaron Paul Kithcart: When Clinical Research Comes Together at ISTH 2026
-
Jul 16, 2026, 18:40Sara Buonomo: Predicting Relapse in Immune-Mediated TTP at ISTH 2026